Form 4: Clene Inc. Director Arjun Desai Acquires Stock Options

Director Arjun Desai acquired 2,943 stock options in Clene Inc. on October 2, 2024, vesting immediately.

Summary

• On October 2, 2024, Arjun Desai, a director of Clene Inc., acquired 2,943 stock options.
• The options were granted under the Clene Inc. Amended 2020 Stock Plan.
• The exercise price is $4.89 per share.
• The options vest immediately upon grant and expire on October 1, 2034.
• Following the transaction, Desai directly owns 2,943 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine filing related to stock option grants, which is generally neutral. It reflects standard corporate governance practices.

Positives

• The immediate vesting of the options could incentivize the director to work towards the company's success.

Industry Context

This is a standard practice for compensating and incentivizing directors in publicly traded companies. Stock options align the director's interests with those of the shareholders.

Comparison to Industry Standards

• Granting stock options to directors is a common practice across the industry to align their interests with shareholders.
• The vesting schedule (immediate in this case) can vary; some companies use phased vesting over several years.
• The exercise price is typically set at or above the market price on the grant date, which is the case here.

Stakeholder Impact

• The granting of stock options can potentially impact shareholders by diluting equity if the options are exercised.
• It incentivizes the director, which could positively impact the company's performance.

Key Dates